US Patent 9856323 Anti-CD22 antibodies
Patent 9856323 was granted and assigned to Bioatla Llc on January, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Article (+268 characters)
Article
Patent abstract
Anti-CD22 antibodies, including isolated nucleic acids that encode at least one such anti-CD22 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Gerhard Frey0
Hwai Wen Chang0
Jay Short0
William Boyle0
Edits on 5 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09856323 Anti-CD22 antibodies US Patent 9856323 Anti-CD22 antibodies
Infobox
Patent Number
098563230
Patent Number
98563230
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
098563230
Date of Patent
January 2, 2018
0Patent Application Number
143968690
Date Filed
April 26, 2013
0Patent Primary Examiner
Edits on 16 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09856323 Anti-CD22 antibodies
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09856323
Date of patent
January 2, 2018
Patent application number
14396869
Date Filed
April 26, 2013
Patent primary examiner
Find more entities like US Patent 9856323 Anti-CD22 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
